Stem Cell Clinical Trials and New Therapies for Patients: Alpha Clinic Director’s Panel
CIRM-funded Alpha Stem Cell Clinics are a network California medical centers that specialize in delivering stem cell clinical trials to patients. Sandra Dillon shares how their work has impacted treatments for her rare cancer. Maria T. Millan, M.D., Mehrdad Abedi, M.D., Daniela A. Bota, M.D., Ph.D., Sheila Chari, Ph.D., Noah Federman, M.D., Catriona Jamieson, M.D., […]
Clinical Evidence on Stem Cell Therapy – Dr. Joy Kong
Recording of Dr Joy Kong speaking at the 9th Annual International Cell Surgical Conference about the clinical evidence that currently exists in stem cell treatments.
Global Stem Cells Market to Generate Revenue of $25.68 Billion By 2028 | More than 80% of Revenue Comes from Adult Stem Cells
Westford,USA, Nov. 02, 2022 (GLOBE NEWSWIRE) — The demand for stem cells market is growing rapidly as the potential for their use in medical treatments expands. In particular, there is great interest in using stem cells to treat a range of degenerative diseases and injuries, as well as to improve the success of organ transplants. Recent advances […]
CAR T-Cell Therapy: Ask Dr. Alaa Ali
Alaa Ali, MD, MSC, is a clinician, instructor, and investigator in clinical and translational research at MedStar Georgetown’s Stem Cell Transplant and Cellular Immunotherapy program. In the following video, Dr. Alaa Ali explains what CAR T-cell therapy is and how it works, what the process is for creating CAR T-cells to fight cancer, the success […]
Parkinson’s & Stem Cell Therapy Research
Stem cells are the body’s building blocks, capable of multiplying itself and creating other differentiated cells. Every day, scientists are learning more and more about their potential, and the use of these cells as an internal repair system. From laboratory test tubes to human trials, stem cells are giving new hope to a myriad of […]
When Should Stem Cell Transplants Be Considered for MPN Treatment?
Dr. Jeanne Palmer, an MPN specialist, discusses when a stem cell transplant is an appropriate treatment option and provides an overview of how risk is assessed in MPN patients. Dr. Jeanne Palmer is a hematologist specializing in myeloproliferative neoplasms (MPNs) and bone marrow transplant at the Mayo Clinic in Arizona. Dr. Palmer also serves as […]
Perinatal Stem Cell Society Calls Emergency Session to Garner Industry Support for FDA
FORT LAUDERDALE, Fla., Oct. 26, 2022 /PRNewswire/ — The Perinatal Stem Cell Society has organized a workshop Nov. 3 in Fort Lauderdale, Fla. and streamed to unite the biologics industry and work with the FDA towards a patient-centered goal. “I called this one-day workshop so the industry can partner with the Food and Drug Administration to find solutions that will enable […]
Developing Regenerative Medicines featuring Dr. Stefan Irion
In episode 228 of the Stem Cell Podcast, Dr. Dayklin James and Dr. Arun Sharma chat with Dr. Stefan Irion, Senior Vice President of Research at BlueRock Therapeutics, a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. He talks about the company’s Parkinson’s disease trial and the challenges […]
ANDREWS MEDICINE AND CELLTEX THERAPEUTICS CORPORATION JOIN FORCES TO BRING CUTTING EDGE TECHNOLOGIES TO ATHLETIC INJURIES
HOUSTON, Oct. 4, 2022 /PRNewswire/ — James R. “Jim” Andrews, MD, Chairman and CEO of Andrews Medicine of Pensacola, Florida, and David G. Eller, Chairman and CEO of Celltex Therapeutics Corporation of Houston, Texas, announced today that together they will form a new biotechnology company to bridge the divide between stem cell research and the […]
Bone Marrow Transplant and Cell Therapies Unit at Tampa General Hospital Brings More Treatment Options to Cancer Patients
TAMPA, Fla., Oct. 3, 2022 /PRNewswire/ — As part of its commitment to world-class, innovative cancer care for the Tampa Bay region and beyond, Tampa General Hospital (TGH) Cancer Institute has established an adult Bone Marrow Transplant (BMT) and Cell Therapies unit that focuses on treating patients with aggressive blood cancers such as leukemias, lymphomas, multiple […]